CoChat
Sign Up
Cited by 137Cutaneous Melanoma Detection and ManagementGlobal Cancer Incidence and ScreeningHealth disparities and outcomes

The DOI matches its Crossref record; 31 of the 32 references it cites were found in a registry or an index.

The ongoing racial disparities in melanoma: An analysis of the Surveillance, Epidemiology, and End Results database (1975-2016)

Open access
Qian, Yingzhi, Johannet, Paul, Sawyers, Amelia, Yu, Jaehong, Osman, Iman, Zhong, Judy·2021·Journal of the American Academy of Dermatology
DOI 10.1016/j.jaad.2020.08.097PMC PMC8049091
Open this paper in CoChat — free account

Abstract

Background Although most patients with cutaneous melanoma are non-Hispanic whites (NHWs), minorities consistently suffer worse melanoma-specific survival (MSS). Much of the literature comes from analyses of registries from the 1990s and 2000s.Objective We sought to evaluate whether and to what degree racial disparity in MSS persists since 2010.Methods We analyzed 381,035 patients from the Surveillance, Epidemiology, and End Results registry. Race categories included Hispanic, NHW, non-Hispanic black (NHB), non-Hispanic Asian or Pacific Islander (NHAPI), and non-Hispanic American Indian/Alaska Native (NHAIAN). We evaluated the association between MSS and race in 3 time periods: before the year 2000, 2000 to 2009, and 2010 or later. NHW was the reference group for all analyses.Results Racial disparity worsened from before the year 2000 to 2010 or later for Hispanic (P < .001), NHB (P = .024), and NHAPI (P < .001) patients. Across all minority groups, patients with localized disease suffered increasing disparity (P = .010 for Hispanic, P < .001 for NHB, P = .023 for NHAPI, and P = .042 for NHAIAN patients). Among those with regional and distant disease, Hispanic patients were the only minority to experience worsening disparity (P = .001 and P = .019, respectively).Limitations Lack of immunotherapy and targeted treatment information.Conclusions Racial disparity in MSS is worsening. Improving postdiagnosis management for minorities with localized disease is imperative to mitigate disparity and improve survival.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jaad.2020.08.097

Cites

31 of 31 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

Sorted by citations

See all 137

Related

See all

Metadata

Authors
Qian, Y., Johannet, P., Sawyers, A., Yu, J., Osman, I., & Zhong, J.
Affiliations
NYU Langone Health (US)
Corresponding author
Zhong, Judy
ORCID
Venue
Journal of the American Academy of Dermatology
Publisher
Elsevier BV
Published
2021-06
Volume
84
Issue
6
Pages
1585-1593
ISSN
0190-9622 (ISSN-L)
DOI
10.1016/j.jaad.2020.08.097
PMC
PMC8049091
OpenAlex
W3080499403
Cited by
137
References
32
Citations by year
2026: 22 · 2025: 30 · 2024: 14 · 2023: 33 · 2022: 25 · 2021: 12
FWCI
6.41
Type
journal article
Language
en
Open access
Licence
Locations
  • Journal of the American Academy of Dermatology (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
NYU Langone Medical Center
Topics
  • Health Sciences › Medicine › Oncology › Cutaneous Melanoma Detection and Management
  • Health Sciences › Medicine › Oncology › Global Cancer Incidence and Screening
  • Social Sciences › Health › Health disparities and outcomes
Keywords
cutaneous melanoma, racial disparities, melanoma-specific survival, Hispanic patients, non-Hispanic Black patients, localized melanoma, SEER database
MeSH terms
Adult, Aged, Asian, Black or African American, Female, Hispanic or Latino, Humans, Male, Melanoma, Middle Aged, Minority Groups, Skin Neoplasms, United States, SEER Program, White People, Native Hawaiian or Pacific Islander, Health Status Disparities

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review